NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Shyangdan D, Clar C, Ghouri N, et al. Insulin Sensitisers in the Treatment of Non-Alcoholic Fatty Liver Disease: A Systematic Review. Southampton (UK): NIHR Journals Library; 2011 Nov. (Health Technology Assessment, No. 15.38.)

Cover of Insulin Sensitisers in the Treatment of Non-Alcoholic Fatty Liver Disease: A Systematic Review

Insulin Sensitisers in the Treatment of Non-Alcoholic Fatty Liver Disease: A Systematic Review.

Show details

List of abbreviations

AISF

Italian Association for the Study of the Liver

ALD

alcohol-related fatty liver disease

ALT

alanine aminotransferase

AST

aspartate aminotransferase

AUROC

area under receiver operating characteristic curve

BAAT

BMI, age, ALT, TG

BAD

BMI, age, T2DM

BARD

BMI, AST/ALT ratio, T2DM

BARG

BMI, age, AST/ALT ratio, HbA1c or glucose

b.i.d.

twice a day

BMI

body mass index

CASP

Critical Appraisal Skills Programme

CK-18

cytokeratin-18

CRN

Clinical Research Network

CT

computerised tomography

DBP

diastolic blood pressure

DCC

Data Coordinating Centre

DURATION

Diabetes therapy Utilization: Researching changes in A1c, weight and other factors Through Intervention with Exenatide ONce weekly

FBC

full blood count

FLD

fatty liver disease

FLIRT

Fatty Liver Improvement with Rosiglitazone Therapy

FPG

fasting plasma glucose

GGT

gamma-glutamyl transferase

GLP-1

glucagon-like peptide-1

HAIR

hypertension, ALT, insulin resistance

HbA1c

glycosylated haemoglobin

HBV

hepatitis B virus

HCC

hepatocellular carcinoma

HCV

hepatitis C virus

HDL

high-density lipoprotein

HOMA–IR

homeostatic model assessment–insulin resistance

HTA

Health Technology Assessment

IQR

interquartile range

ITT

intention to treat

IU

international unit

LDL

low-density lipoprotein

LEAD

Liraglutide Effect and Action in Diabetes

LFT

liver function test

MRE

magnetic resonance elastography

MRI

magnetic resonance imaging

MRS

magnetic resonance spectroscopy

NAFL

non-alcoholic fatty liver

NAFLD

non-alcoholic fatty liver disease

NAS

NAFLD activity score

NASH

non-alcoholic steatohepatitis

NEFA

non-esterified fatty acid

NFS

NAFLD Fibrosis Score

NGT

normal glucose tolerance

NICE

National Institute for Health and Clinical Excellence

NIHR

National Institute for Health Research

PedsQL

Pediatric Quality of Life Inventory

PPAR

peroxisome proliferators-activated receptor

QoL

quality of life

RCT

randomised controlled trial

SBP

systolic blood pressure

SD

standard deviation

SE

standard error

SF-36

Short Form questionnaire-36 items

SIGN

Scottish Intercollegiate Guidelines Network

T2DM

type 2 diabetes mellitus

TC

total cholesterol

TE

transient elastography

TG

triglyceride

TONIC

Treatment of Non-alcoholic Fatty Liver Disease in Children

TZD

thiazolidinedione

USG

ultrasonography

UDCA

ursodeoxycholic acid

All abbreviations that have been used in this report are listed here unless the abbreviation is well known (e.g. NHS), or it has been used only once, or it is a non-standard abbreviation used only in figures/tables/appendices, in which case the abbreviation is defined in the figure legend or in the notes at the end of the table.

© 2011, Crown Copyright.

Included under terms of UK Non-commercial Government License.

Bookshelf ID: NBK98339

Views

  • PubReader
  • Print View
  • Cite this Page
  • PDF version of this title (995K)

Other titles in this collection

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...